Subversion of interleukin-1-mediated host defence by a nasal carrier strain of Staphylococcus aureus

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Quinn, Gerry A ^b   Tarwater, Patrick M ^c   Cole, Alexander M ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bacteria bacterial immunity; Cytokines; Innate immunity

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CARRIER; BIOFILM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

BIOFILMS; CARRIER STATE; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; NASAL MUCOSA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68249135251     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02952.x     Document Type: Article

References (27)

1. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001 344 : 11 16. (Pubitemid 32064839)
2. Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A, Ganz T. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001 8 : 1064 9.
3. Ogsten A. Micro-organisms in surgical diseases. BMJ 1881 1 : 369 75.
4. Ogston A. Micrococcus poisoning. J Anat Physiol 1882 16 : 526 67.
5. Kostenko V, Ceri H, Martinuzzi RJ. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media. FEMS Immunol Med Microbiol 2007 51 : 277 88.
6. Pfeltz RF, Wilkinson BJ. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Curr Drug Targets Infect Disord 2004 4 : 273 94.
7. Hashimoto M, Tawaratsumida K, Kariya H, Aoyama K, Tamura T, Suda Y. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 2006 18 : 355 62.
8. Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T. Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol 2002 169 : 6985 91.
9. Midorikawa K, Ouhara K, Komatsuzawa H et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 2003 71 : 3730 9.
10. Cole AM, Kim YH, Tahk S, Hong T, Weis P, Waring AJ, Ganz T. Calcitermin, a novel antimicrobial peptide isolated from human airway secretions. FEBS Lett 2001 504 : 5 10.
11. Shuter J, Hatcher VB, Lowy FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996 64 : 310 18.
12. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun 2004 72 : 6685 8.
13. Quinn GA, Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 2007 122 : 80 9.
14. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999 67 : 3267 75.
15. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001 167 : 623 7.
16. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003 74 : 448 55.
17. Yount NY, Waring AJ, Gank KD, Welch WH, Kupferwasser D, Yeaman MR. Structural correlates of antimicrobial efficacy in IL-8 and related human kinocidins. Biochim Biophys Acta 2007 1768 : 598 608.
18. Lee IH, Cho Y, Lehrer RI. Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 1997 65 : 2898 903.
19. Light IJ, Walton RL, Sutherland JM, Shinefield HR, Brackvogel V. Use of bacterial interference to control a staphylococcal nursery outbreak. Deliberate colonization of all infants with the 502A strain of Staphylococcus aureus. Am J Dis Child 1967 113 : 291 300.
20. Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D. Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med 1999 160 : 961 7.
21. Kanangat S, Bronze MS, Meduri GU, Postlethwaite A, Stentz F, Tolley E, Schaberg D. Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1beta and IL-1 receptor antagonist. J Infect Dis 2001 183 : 65 9.
22. McLaughlin RA, Hoogewerf AJ. Interleukin-1beta-induced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures. Microb Pathog 2006 41 : 67 79.
23. Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002 70 : 6339 45.
24. Kanangat S, Postlethwaite A, Cholera S, Williams L, Schaberg D. Modulation of virulence gene expression in Staphylococcus aureus by interleukin-1beta: novel implications in bacterial pathogenesis. Microbes Infect 2007 9 : 408 15.
25. Porat R, Clark BD, Wolff SM, Dinarello CA. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 1991 254 : 430 2.
26. Liener K, Leiacker R, Lindemann J, Rettinger G, Keck T. Nasal mucosal temperature after exposure to cold, dry air and hot, humid air. Acta Otolaryngol 2003 123 : 851 6.
27. Kim KS, Le J. IL-1 beta and Escherichia coli. Science 1992 258 : 1562 3.